Corona Remedies schedules Q4 FY26 earnings conference call for May 12, 2026 at 11:00 AM IST.
Management participants include MD & CEO Nirav Mehta, Joint MD Ankur Mehta, and CFO Bhavin Bhagat.
Ambit Capital's Gaurav Tinani will moderate the call to discuss fourth quarter and full year results.
The disclosure is made pursuant to SEBI Listing Regulations Regulation 30 and Schedule III.